MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group, page-171

  1. 3,952 Posts.
    lightbulb Created with Sketch. 1352
    To much going on for a in depth disscuion on Novartis . Might start something at the weekend.

    Looks like we know that any CLBP trial will get good enrollment and support. These guys are the real deal and more than likely not attached to big pharmaceutical companies.

    I made the suggestion a while back that MSB may have been looking in the wrong place for partnerships and funding . At the time I suggested health insurance companies being less reliant on old drugs for revenue.
    This in my opinion is far better than any partnership from a big pharmaceutical or insurance company, they are only interested in the outcome for the patients and are at the front lines treating patients.

    Good luck all



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.